{"id":"W3018308921","doi":"10.1186/s12885-020-06826-0","title":"EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"National Center for Advancing Translational Sciences; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Osimertinib; T790M; Oncology; Internal medicine; Epidermal growth factor receptor; Surgical oncology; Lung cancer; Resistance mutation; Targeted therapy; Cancer; Erlotinib; Gefitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002554012,0.0001763446,0.0002166844,0.00008655215,0.0001649808,0.00004139087,0.00002114767,0.00005732613,0.0001856684],"category_scores_gemma":[0.0004086549,0.000114216,0.00003599134,0.0002777378,0.00002620692,0.0001510928,0.00001352611,0.00006784035,0.000008917731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006451721,"about_ca_system_score_gemma":0.0002365456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003065673,"about_ca_topic_score_gemma":0.001879276,"domain_scores_codex":[0.9989964,0.00003139605,0.0002777338,0.0003379101,0.0001769523,0.0001796296],"domain_scores_gemma":[0.999357,0.0001679145,0.0001097539,0.00008604407,0.0001139927,0.0001652932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006847082,0.0005087097,0.8051505,0.00007409997,0.00006755257,0.00002400768,0.00233846,0.000252073,0.001268904,0.000007840507,0.001079352,0.1885438],"study_design_scores_gemma":[0.01195986,0.003245709,0.9636484,0.0007473012,0.0002072284,0.000004129652,0.0001564753,0.003347076,0.0134212,0.000006455049,0.00296004,0.0002961545],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968293,0.0003002828,0.00004007103,0.001364517,0.0002044426,0.0009870783,0.0001265255,0.00004512458,0.0001026042],"genre_scores_gemma":[0.994985,0.00006261974,0.003506312,0.000412696,0.0003826595,0.0003017031,0.0001592416,0.00002765374,0.0001621531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1882476,"threshold_uncertainty_score":0.4657594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0778234020272974,"score_gpt":0.339499494972079,"score_spread":0.2616760929447816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}